32 results match your criteria: "Australia (D.S.C.); The University of Notre Dame[Affiliation]"
Circ Heart Fail
September 2024
Department of Medicine, Royal Melbourne Hospital, Melbourne, VIC, Australia (J.W., P.S.J., L.J.B., W.M.W.).
Circulation
August 2024
Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology and Experimental Therapeutics; Divisions of Heart Rhythm Services and Pediatric Cardiology, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN (C. Bell, J.M.B., B.C.C., C.H.-T., M.J.A.).
Background: Whether vigorous exercise increases risk of ventricular arrhythmias for individuals diagnosed and treated for congenital long QT syndrome (LQTS) remains unknown.
Methods: The National Institutes of Health-funded LIVE-LQTS study (Lifestyle and Exercise in the Long QT Syndrome) prospectively enrolled individuals 8 to 60 years of age with phenotypic and/or genotypic LQTS from 37 sites in 5 countries from May 2015 to February 2019. Participants (or parents) answered physical activity and clinical events surveys every 6 months for 3 years with follow-up completed in February 2022.
Europace
March 2024
Atrial Fibrillation NETwork (AFNET), Muenster, Germany.
Aims: Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA).
Methods And Results: Eighty-three international experts met in Münster for 2 days in September 2023.
Int J Mol Sci
December 2023
Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Her-2/neu-targeting therapy by passive application with trastuzumab is associated with acquired resistance and subsequent metastasis development, which is attributed to the upregulation of tumoral PD-L1 expression and the downregulation of Her-2/neu. We aimed to investigate this association, following active immunization with our recently constructed B-cell peptide-based Her-2/neu vaccines in both preclinical and clinical settings. Immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and combined positive score (CPS) were applied to evaluate Her-2/neu and PD-L1 expression using a murine syngeneic tumor model for Her-2/neu lung metastases and tumor biopsies from a gastric cancer patient with disease progression.
View Article and Find Full Text PDFInt J Epidemiol
December 2023
Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, UK.
Background: In pregnancy, women are encouraged to cease smoking and limit caffeine intake. We employed objective definitions of smoking and caffeine exposure to assess their association with adverse outcomes.
Methods: We conducted a case cohort study within the Pregnancy Outcome Prediction study to analyse maternal serum metabolomics in samples from 12, 20, 28 and 36 weeks of gestational age.
Ann Intern Med
May 2023
ViRx@Stanford, Stanford Biosecurity and Pandemic Preparedness Initiative, Stanford, California; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada; Cytel, Vancouver, British Columbia, Canada; and Platform Life Sciences, Vancouver, British Columbia, Canada (E.J.M.).
Background: Previous trials have demonstrated the effects of fluvoxamine alone and inhaled budesonide alone for prevention of disease progression among outpatients with COVID-19.
Objective: To determine whether the combination of fluvoxamine and inhaled budesonide would increase treatment effects in a highly vaccinated population.
Design: Randomized, placebo-controlled, adaptive platform trial.
Eur J Neurol
April 2023
Department of Medicine, CORe, University of Melbourne, Melbourne, Victoria, Australia.
Background And Purpose: This study assessed the effect of patient characteristics on the response to disease-modifying therapy (DMT) in multiple sclerosis (MS).
Methods: We extracted data from 61,810 patients from 135 centers across 35 countries from the MSBase registry. The selection criteria were: clinically isolated syndrome or definite MS, follow-up ≥ 1 year, and Expanded Disability Status Scale (EDSS) score ≥ 3, with ≥1 score recorded per year.
Autism Adulthood
June 2022
estas, Seoul, Korea.
Circulation
November 2022
Monash Heart, Clayton, Australia (D.T.W., S.J.N.).
Coronary artery disease (CAD) remains the leading cause of adult mortality globally. Targeting known modifiable risk factors has had substantial benefit, but there remains a need for new approaches. Improvements in invasive and noninvasive imaging techniques have enabled an increasing recognition of distinct quantitative phenotypes of coronary atherosclerosis that are prognostically relevant.
View Article and Find Full Text PDFCell Rep Med
June 2022
Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia. Electronic address:
Background: In REDUCE LAP-HF II (A Study to Evaluate the Corvia Medical, Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure), implantation of an atrial shunt device did not provide overall clinical benefit for patients with heart failure with preserved or mildly reduced ejection fraction. However, prespecified analyses identified differences in response in subgroups defined by pulmonary artery systolic pressure during submaximal exercise, right atrial volume, and sex. Shunt implantation reduces left atrial pressures but increases pulmonary blood flow, which may be poorly tolerated in patients with pulmonary vascular disease (PVD).
View Article and Find Full Text PDFArterioscler Thromb Vasc Biol
March 2022
Cardiovascular Discovery Group, Kolling Institute of Medical Research (S.T.V., K.A.K., T.H., M.F., G.A.F.) University of Sydney, Australia.
Background: Treating known risk factors for coronary artery disease (CAD) has substantially reduced CAD morbidity and mortality. However, a significant burden of CAD remains unexplained. Immunoglobulin E sensitization to mammalian oligosaccharide galactose-α-1,3-galactose (α-Gal) was recently associated with CAD in a small observational study.
View Article and Find Full Text PDFHypertension
November 2021
Centre for Cardiovascular Biology and Disease Research and Department of Physiology, Anatomy and Microbiology, School of Life Sciences, La Trobe University, Bundoora, Australia (J.M.T., B.M.H., M.J., P.S., N.S., H.D., T.V.A., C.G.S., A.V., G.R.D.).
IL-18 (interleukin-18) is elevated in hypertensive patients, but its contribution to high blood pressure and end-organ damage is unknown. We examined the role of IL-18 in the development of renal inflammation and injury in a mouse model of low-renin hypertension. Hypertension was induced in male C57BL6/J (WT) and IL-18−/− mice by uninephrectomy, deoxycorticosterone acetate (2.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
July 2021
Royal Prince Alfred Hospital, Camperdown NSW, Australia (D.S.C.).
Circulation
March 2021
Sydney Medical School, Faculty of Medicine and Health (C.E.V., D.S.C., J.A., D.S.W., R.C.), University of Sydney, New South Wales, Australia.
Background: Neurocognitive outcomes beyond childhood in people with a Fontan circulation are not well defined. This study aimed to investigate neurocognitive functioning in adolescents and adults with a Fontan circulation and associations with structural brain injury, brain volumetry, and postnatal clinical factors.
Methods: In a binational study, participants with a Fontan circulation without a preexisting major neurological disability were prospectively recruited from the Australia and New Zealand Fontan Registry.
Circulation
July 2020
Department of Cardiology, Boston Children's Hospital (A.R.O., J.R.), Harvard Medical School, MA.
J Trauma Acute Care Surg
September 2020
From the Intensive Care Unit (A.F.), Royal Adelaide Hospital, Adelaide, South Australia, Australia; Discipline of Acute Care Medicine (A.F.), Adelaide Medical School, University of Adelaide, Adelaide, South Australia; Auckland City Hospital (I.D.S.C.); University of Auckland (I.D.S.C.), Auckland, New Zealand; Trauma Services (Z.J.B.), John Hunter Hospital; Hunter >New England Trauma System (Z.J.B.), New Lambton Heights, Australia; University of Newcastle (Z.J.B.); and New Zealand Trauma Network (S.I.), Auckland, New Zealand.
Sci Rep
February 2020
The Ritchie Centre, Department of Obstetrics and Gynaecology, Monash University, 252 Clayton Road, Clayton, 3168, Victoria, Australia.
External cephalic version (ECV) is associated with a moderate degree of pain. Virtual reality (VR) is a technology that has shown promise in offering procedural analgesia. We undertook a clinical pilot to assess the viability of VR to reduce pain during ECV.
View Article and Find Full Text PDFCirculation
December 2016
From Paris Cardiovascular Research Center, INSERM Unit 970, France (W.B., E.M., N.K., F.D., D.J., L.L., F.B., A.C., and X.J.); Université Paris Descartes-Sorbonne Paris Cité, France (W.B., E.M., B.P., N.K., F.D., F.B, A.C., G.M., X.J.); Cardiology Department, Georges Pompidou European Hospital, Paris, France (W.B., E.M., N.K., X.J.); Paris Sudden Death Expertise Center, France (W.B., E.M., N.K., F.D., D.J., L.L., F.B., A.C.); Medical Intensive Care Unit, Cochin Hospital, Paris, France (A.C.); Department of Respiratory Disease, Georges Pompidou European Hospital, Paris, France (B.P., G.M.); INSERM U UMRS 1140, Paris, France (B.P.); Emergency Department, Cochin-Hotel-Dieu Hospital, Paris, France (F.D.); Brigade de Sapeurs Pompiers de Paris, France (D.J.); Inten-sive Care Unit, SAMU 75, Necker Enfants-Malades Hospital, Paris, France (L.L.); INSERM UMRS 970, CIC 1418, Paris, France (G.M.); and Sydney Medical School, Australia (D.S.C.).
Pharmacol Res
February 2017
Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, Australia; Department of Surgery, School of Clinical Sciences, Monash Health, Clayton, Australia. Electronic address:
Objective: To determine whether a clinically-utilised IL-1 receptor antagonist, anakinra, reduces renal inflammation, structural damage and blood pressure (BP) in mice with established hypertension.
Methods: Hypertension was induced in male mice by uninephrectomy, deoxycorticosterone acetate (2.4mg/d,s.
J Clin Endocrinol Metab
December 2016
Center for Reproductive Medicine and Andrology (H.M.B.), Martin Luther University, Halle-Wittenberg, D-06120 Halle, Germany; Center of Reproductive Medicine and Andrology (M.Z.), University of Münster, Münster, Germany; Medical Research Council Centre for Reproductive Health (R.A.A.), Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, United Kingdom; Anzac Research Institute (D.J.H.), University of Sydney, and Andrology Department, Concord Hospital, Sydney, Australia; Department of Medical Biology (S.W.L.), Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Hudson Institute of Medical Research (R.I.M.), Monash Medical Centre, Melbourne, Australia; Clinic of Gynecology and Physiopathology of Reproduction (M.C.M.), University of Bologna, Bologna, Italy; National Institute of Health and Family Welfare (M.M.M.), New Delhi, India; Instituto Chileno de Medicina Reproductiva (G.N.), Santiago, Chile; Department of Endocrinology (F.C.W.W.), Manchester Royal Infirmary, Manchester, United Kingdom; Department of Reproductive Health and Research (M.R.P.F., N.A.H., K.M.V.), World Health Organization, Geneva 1211, Switzerland; and CONRAD (M.M.C., K.A.L., D.S.C.), Arlington, Virginia 22209.
Context: The development of a safe and effective reversible method of male contraception is still an unmet need.
Objective: Evaluation of suppression of spermatogenesis and contraceptive protection by coadministered im injections of progestogen and testosterone.
Design: Prospective multicentre study.
Circulation
June 2016
From Cardiovascular and Thoracic Department, San Raffaele Hospital, Milan, Italy (A.G.); St. Raphael of St. Francis Nsambya Hospital, Kampala, Uganda (A.G.); Paris Cardiovascular Research Center (INSERM U970), Cardiology & Development, Paris, France (M.M., K.N., X.J., E.M.); Instituto Nacional de Saúde, Maputo, Mozambique (A.O.M.); Division of Cardiology, Department of Medicine, Makerere University, Kampala, Uganda (J.F.); Institut du Thorax, Nantes, France (M.L.); Maputo Heart Institute, Maputo, Mozambique (M.L., B.F., D.S., X.J., E.M.); European Georges Pompidou Hospital, Cardiology Department, Paris, France (M.M., X.J., E.M.); Necker Enfants Malades Hospital, Pediatric Cardiology, Paris, France (D.S.); Maxcure Hospitals, Hyderabad, India (K.N.); Sydney Medical School, Sydney, Australia (D.S.C.); and Paris Descartes University, Paris, France (D.S., X.J., E.M.).
Tropical endomyocardial fibrosis (EMF) is a neglected disease of poverty that afflicts rural populations in tropical low-income countries, with some certain high-prevalence areas. Tropical EMF is characterized by the deposition of fibrous tissue in the endomyocardium, leading to restrictive physiology. Since the first descriptions in Uganda in 1948, high-frequency areas for EMF have included Africa, Asia, and South America.
View Article and Find Full Text PDFEndocrinology
January 2016
Department of Physiology, Development and Neuroscience (M.J.D.B., M.B., A.D., A.H., F.B.P.W., A.L.F., A.J.F.), University of Cambridge, Cambridge CB2 3EG, United Kingdom; Department of Medicine (S.L.K.), University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Department of Obstetrics and Gynaecology (G.C.S.S., D.S.C.-J.), University of Cambridge, The Rosie Hospital, Cambridge CB2 0SW, United Kingdom; School of Animal Biology (D.B.), University of Western Australia, Crawley, Perth, Western Australia, Australia 60095; and Department of Biological and Medical Sciences (A.J.F.), Oxford Brookes University, Oxford OX3 0BP, United Kingdom.
In human and ovine fetuses, glucocorticoids stimulate leptin secretion, although the extent to which leptin mediates the maturational effects of glucocorticoids on pulmonary development is unclear. This study investigated the effects of leptin administration on indices of lung structure and function before birth. Chronically catheterized singleton sheep fetuses were infused iv for 5 days with either saline or recombinant ovine leptin (0.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
November 2015
Department of Obstetrics and Gynaecology (P.M.S., F.D.S.C.), University of Melbourne, Parkville, Victoria, Australia; Royal Women's Hospital (P.M.S., A.N., F.D.S.C.), Melbourne, Victoria, Australia; Department of Obstetrics (E.A.J.), Paulista School of Medicine - Federal University of São Paulo, São Paulo-SP, Brazil; Pregnancy Research Centre (P.M.S., F.D.S.C.), Royal Women's Hospital, Melbourne, Victoria, Australia.
Context: Thyroid disease in pregnancy is increasing with rising average maternal ages in developed countries. The evidence for an association between preterm birth and thyroid disease has been confounded by small studies with varying outcomes and methodology.
Objective: The aim of this meta-analysis is to review the literature regarding thyroid disease including subclinical and overt hypothyroidism, hyperthyroidism, and isolated hypothyroxinemia and the specific outcome of preterm birth.
J Am Heart Assoc
August 2015
Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia (G.J.M., J.B., D.S.C., S.P.) Sydney Medical School, The University of Sydney, New South Wales, Australia (G.J.M., S.R., Q.X., C.B., D.S.C., S.P.) Heart Research Institute, Sydney, New South Wales, Australia (S.R., C.B., D.S.C., S.P.).
Background: Interleukin (IL)-1β, IL-18, and downstream IL-6 are key inflammatory cytokines in the pathogenesis of coronary artery disease. Colchicine is believed to block the NLRP3 inflammasome, a cytosolic complex responsible for the production of IL-1β and IL-18. In vivo effects of colchicine on cardiac cytokine release have not been previously studied.
View Article and Find Full Text PDF